Is Compugen Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: CGEN) stock is to Buy CGEN stock.
Out of 3 analysts, 1 (33.33%) are recommending CGEN as a Strong Buy, 1 (33.33%) are recommending CGEN as a Buy, 0 (0%) are recommending CGEN as a Hold, 1 (33.33%) are recommending CGEN as a Sell, and 0 (0%) are recommending CGEN as a Strong Sell.
What is CGEN's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CGEN) forecast ROE is N/A, which is considered weak.
What is CGEN's Price Target?
According to 3 Wall Street analysts that have issued a 1 year CGEN price target, the average CGEN price target is $6.83, with the highest CGEN stock price forecast at $13.00 and the lowest CGEN stock price forecast at $0.50.
On average, Wall Street analysts predict that Compugen's share price could reach $6.83 by May 26, 2024. The average Compugen stock price prediction forecasts a potential upside of 550.76% from the current CGEN share price of $1.05.
What is CGEN's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CGEN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.